Chronic kidney disease-associated pruritus: what is known and its application in children

Shweta Shah1, Elizabeth Onugha2, Sarah J Swartz2

  • 1Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. ssshah@texaschildrens.org.

Insights

Chronic kidney disease-associated pruritus (CKD-aP), or uremic pruritus, significantly impacts dialysis patients. Early recognition and treatment in children are crucial due to limited data and available therapies.

Area of Science:

  • Nephrology
  • Dermatology
  • Pediatrics

Background:

  • Chronic kidney disease-associated pruritus (CKD-aP), also known as uremic pruritus, is a common and severe symptom in patients with kidney failure undergoing kidney replacement therapy.
  • Severe pruritus in dialysis patients is linked to adverse outcomes and significantly diminishes quality of life.
  • Limited data exists regarding CKD-aP specifically in pediatric populations.

Purpose of the Study:

  • To review the current understanding of CKD-aP epidemiology, clinical features, assessment tools, and treatment options.
  • To highlight the importance of recognizing and managing pruritus in children with chronic kidney disease.
  • To emphasize the need for better-studied therapeutic interventions for pediatric CKD-aP.

Main Methods:

  • Literature review of epidemiology, clinical characteristics, pruritus scoring systems, and therapeutic options for CKD-aP.
  • Focus on data relevant to patients with chronic kidney disease and those on dialysis.
  • Specific attention to the pediatric population and the scarcity of research therein.

Main Results:

  • CKD-aP is multifactorial, impacts quality of life, and correlates with poor outcomes in dialysis patients.
  • Optimizing dialysis and correcting electrolyte imbalances are key management strategies.
  • A range of treatments exist, but few are well-studied in children.

Conclusions:

  • Optimal management of CKD-aP requires awareness of symptom severity and impact on quality of life.
  • Earlier recognition and treatment of pruritus in children with chronic kidney disease are imperative.
  • Further research is needed to establish effective and well-studied treatments for pediatric CKD-aP.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
46
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
49
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
54
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
31
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
20